Summit Therapeutics, Inc. · 1 day ago
Director, Health Economics & Outcomes Research
Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on improving quality of life and addressing unmet medical needs. They are seeking a Director of Health Economics & Outcomes Research to lead initiatives that enhance product value and inform access strategies for their novel immunotherapy, Ivonescimab.
BiotechnologyHealth CareMedical DeviceTherapeutics
Responsibilities
Lead global and regional HEOR strategies and evidence generation projects to support market access and product value
Collaborate with Medical Affairs and Market Access to integrate HEOR initiatives into broader strategies and stakeholder engagement plans
Oversee the development, review, and dissemination of high-quality HEOR outputs, including protocols, analytic plans, publications, and field materials
Provide training and develop relevant health care economic information (HCEI) materials to support field teams
Support value demonstration tactics for Health Technology Assessment (HTA), including EU Joint Clinical Assessment (JCA) and payer assessments
Maintain awareness of the quickly evolving global HTA and reimbursement landscape, help educate organization on developments within HEOR
Ensure scientific rigor and strategic alignment in all evidence generation activities
Lead development of high-quality publications, posters, and presentations to communicate HEOR findings effectively
Develop and maintain strong alignment with the managed care liaison team to obtain insights from external stakeholders and adjust evidence generation plans accordingly
All other duties as assigned
Qualification
Required
Advanced degree (Master's, PharmD or PhD) in Health Economics, Epidemiology, Outcomes Research, Public Health or related field
Minimum 8+ years relevant experience in healthcare industry with direct experience in global value proposition development, payer, HTA, and relevant policymaker interactions and strong patient-centered focus
Direct experience in Oncology, preferably non-small cell lung cancer (NSCLC)
Expertise in US and global market access, reimbursement processes, and health technology assessment methods
Proficiency in cost effectiveness analysis (CEA), budget impact modeling (BIM), systematic literature reviews (SLRs), indirect treatment comparisons (ITCs), statistical analyses, and real-world evidence (RWE) generation
Strong analytical capabilities and excellent communication skills, with a track record of peer-reviewed publications
Ability to work collaboratively across diverse teams and manage multiple stakeholders, and proactively drive goals
Benefits
Bonus
Stock
Benefits
Other applicable variable compensation
Company
Summit Therapeutics, Inc.
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs.
Funding
Current Stage
Public CompanyTotal Funding
$1.79BKey Investors
CARB-XEurofarmaBiomedical Advanced Research and Development Authority (BARDA)
2025-10-21Post Ipo Equity· $500M
2024-09-11Post Ipo Equity· $235M
2024-06-03Post Ipo Equity· $200M
Recent News
2025-12-09
2025-12-05
Company data provided by crunchbase